Cargando…
Responses of primary human nasal epithelial cells to EDIII-DENV stimulation: the first step to intranasal dengue vaccination
BACKGROUND: About half of the world’s population are living in the endemic area of dengue viruses implying that a rapid-mass vaccination may be required. In addition, a major target of dengue vaccine are children, thus, a needle-free administration is more attractive. These problems may be overcome...
Autores principales: | Nantachit, Nattika, Sunintaboon, Panya, Ubol, Sukathida |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991056/ https://www.ncbi.nlm.nih.gov/pubmed/27538960 http://dx.doi.org/10.1186/s12985-016-0598-z |
Ejemplares similares
-
The STING Ligand and Delivery System Synergistically Enhance the Immunogenicity of an Intranasal Spike SARS-CoV-2 Vaccine Candidate
por: Jearanaiwitayakul, Tuksin, et al.
Publicado: (2022) -
Intranasal Administration of RBD Nanoparticles Confers Induction of Mucosal and Systemic Immunity against SARS-CoV-2
por: Jearanaiwitayakul, Tuksin, et al.
Publicado: (2021) -
The Adjuvant Activity of BCG Cell Wall Cytoskeleton on a Dengue Virus-2 Subunit Vaccine
por: Jearanaiwitayakul, Tuksin, et al.
Publicado: (2023) -
Immunogenic Properties of a BCG Adjuvanted Chitosan Nanoparticle-Based Dengue Vaccine in Human Dendritic Cells
por: Hunsawong, Taweewun, et al.
Publicado: (2015) -
Subversion of Innate Defenses by the Interplay between DENV and Pre-Existing Enhancing Antibodies: TLRs Signaling Collapse
por: Modhiran, Naphak, et al.
Publicado: (2010)